Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912658 | 0.86 | MAOA (0.47) | ACHEHPGDALDH1A1KDM4ECYP1A2 | |
| SCHEMBL10492363 | 0.85 | CYP1A2 (0.38) | HPGDALDH1A1TP53POLBMAPT | |
| SCHEMBL9125469 | 0.80 | — | — | |
| SCHEMBL9124669 | 0.79 | ABCG2 (0.33) | HPGDABCG2ITGB2ICAM1ITGAL | |
| SCHEMBL9122176 | 0.79 | MAPT (0.35) | ACHEHPGDCA12CA9ALDH1A1 | |
| SCHEMBL10492375 | 0.79 | CA1 (0.36) | HPGDCA12CA1CA2CA7 | |
| SCHEMBL9124534 | 0.79 | AHR (0.39) | — | |
| SCHEMBL12875556 | 0.79 | BCHE (0.42) | ACHEHPGDCA12CA1CA2 | |
| SCHEMBL11509206 | 0.79 | BCHE (0.42) | ACHEHPGDCA12CA1CA2 | |
| SCHEMBL9122194 | 0.78 | PDE4B (0.36) | ACHECA4ALDH1A1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2547822-B1 | PROCESS FOR FIBRILLATING LIGNOCELLULOSIC MATERIAL, FIBRES AND THEIR USE | UNIV HELSINKI (FI) | 2014-07-02 | — | — | EP | disclosed |
| US-8198434-B2 | Process for preparing cefsulodin sodium | IDEXX LABORATORIES, INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-8198434-B2 | Process for preparing cefsulodin sodium | IDEXX LABORATORIES, INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-20100113768-A1 | PROCESS FOR PREPARING CEFSULODIN SODIUM | IDEXX LABORATORIES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100113768-A1 | PROCESS FOR PREPARING CEFSULODIN SODIUM | IDEXX LABORATORIES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-7622487-B2 | Piperidine derivative, process for producing the same, and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20090186874-A1 | Carboxamide derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| US-7439289-B2 | Benzoylresorcinol-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION (US) | 2008-10-21 | — | — | US | disclosed |
| US-7439289-B2 | Benzoylresorcinol-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION (US) | 2008-10-21 | — | — | US | disclosed |
| US-7365113-B2 | Phosphate ester flame retardants from resorcinol-ketone reaction products | INDSPEC CHEMICAL CORPORATION | 2008-04-29 | — | — | US | disclosed |
| EP-0216385-A2 | Antibacterial compounds | Takeda Chemical Industries, Ltd. (JP) | 1987-04-01 | — | — | EP | disclosed |
| US-4642365-A | REACTING A PYROCATECHOL DERIVATIVE AND DIHALOPHOSPHOROUS COMPOUND | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-02-10 | — | — | US | disclosed |
| EP-0203271-A2 | Antibacterial compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1986-12-03 | — | — | EP | disclosed |
| WO-1986005183-A1 | ANTIBACTERIAL COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-09-12 | — | — | WO | disclosed |
| EP-0164113-A2 | 3-pyrazolo(1,5-a)pyridinium cephem compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-12-11 | — | — | EP | disclosed |
| EP-0164122-A2 | Cephem compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-12-11 | — | — | EP | disclosed |
| EP-0160969-A2 | Cephem compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-13 | — | — | EP | disclosed |
| EP-0160252-A2 | Antibacterial compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-06 | — | — | EP | disclosed |
| EP-0135683-A1 | Method for production of cephalosporin compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0074611-A2 | Method for production of cephalosporin compounds | Takeda Chemical Industries, Ltd. (JP) | 1983-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186874-A1 | Carboxamide derivative and use thereof | NTSR2, NTSR1, CNR2 | P2RX4 587/4885ACHE 898/4885HPGD 600/4885 |
| US-20100113768-A1 | PROCESS FOR PREPARING CEFSULODIN SODIUM | PEF1, PCSK9, SLC6A5 | P2RX4 4019/4885ACHE 2520/4885HPGD 576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.